AdvisorNet Financial, Inc - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
AdvisorNet Financial, Inc ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$103
-63.5%
5
-16.7%
0.00%
Q2 2023$282
+34.3%
6
+20.0%
0.00%
Q1 2023$210
+37.3%
5
+25.0%
0.00%
Q4 2022$153
-98.9%
4
-98.7%
0.00%
-100.0%
Q3 2021$14,000
-26.3%
310
-5.5%
0.00%0.0%
Q2 2021$19,000
-17.4%
328
+5.8%
0.00%
-50.0%
Q1 2021$23,000
-34.3%
310
-22.5%
0.00%
-33.3%
Q4 2020$35,000
+191.7%
400
+150.0%
0.00%
+200.0%
Q4 2019$12,0001600.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders